HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Noa Galtung Selected Research
Noa Galtung Research Topics
Disease
5
COVID-19
09/2022 - 01/2021
3
Infections
05/2024 - 10/2021
2
Bacterial Infections (Bacterial Infection)
05/2024 - 10/2021
2
Sepsis (Septicemia)
05/2024 - 10/2022
1
Clinical Deterioration
05/2024
1
Coinfection
09/2022
1
Inflammation (Inflammations)
12/2021
1
Cardiovascular Diseases (Cardiovascular Disease)
12/2021
1
Virus Diseases (Viral Diseases)
10/2021
1
Activated Protein C Resistance (APC Resistance)
01/2021
Drug/Important Bio-Agent (IBA)
2
Biomarkers (Surrogate Marker)
IBA
05/2024 - 10/2022
2
Leukocyte L1 Antigen Complex (Calgranulin)
IBA
05/2024 - 01/2021
1
Messenger RNA (mRNA)
IBA
10/2022
1
Anti-Bacterial Agents (Antibiotics)
IBA
09/2022
1
Proteins (Proteins, Gene)
FDA Link
12/2021
1
Proteome
IBA
12/2021
1
Blood Proteins (Serum Proteins)
IBA
12/2021
1
Procalcitonin
IBA
10/2021
1
RNA (Ribonucleic Acid)
IBA
10/2021
1
Thromboplastin (Tissue Factor)
IBA
01/2021
1
Fibrinogen (Factor I)
FDA Link
01/2021
1
Protein C
IBA
01/2021
1
Cell Adhesion Molecules
IBA
01/2021
1
Lupus Coagulation Inhibitor (Lupus Anticoagulant)
IBA
01/2021
1
Protein S
IBA
01/2021
1
Plasminogen Activators (Plasminogen Activator)
IBA
01/2021
1
Plasminogen
IBA
01/2021
1
Antithrombins
IBA
01/2021
1
Factor V (Coagulation Factor V)
IBA
01/2021